Baldwin Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
14,320
-775
-5% -$63.9K 0.13% 90
2025
Q4
$1.29M Buy
15,095
+10
+0.1% +$821 0.15% 86
2025
Q3
$1.17M Buy
15,085
+9,940
+193% +$777K 0.13% 98
2025
Q2
$402K Buy
+5,145
New +$384K 0.05% 166
2024
Q3
Sell
-2,347
Closed -$217K 216
2024
Q2
$217K Sell
2,347
-600
-20% -$53.1K 0.03% 197
2024
Q1
$282K Sell
2,947
-108
-4% -$9.07K 0.04% 188
2023
Q4
$233K Sell
3,055
-50
-2% -$3.48K 0.04% 189
2023
Q3
$215K Sell
3,105
-100
-3% -$8.04K 0.04% 184
2023
Q2
$302K Sell
3,205
-600
-16% -$52.1K 0.05% 168
2023
Q1
$315K Sell
3,805
-285
-7% -$22.4K 0.06% 170
2022
Q4
$305K Buy
4,090
+350
+9% +$27K 0.06% 171
2022
Q3
$309 Hold
3,740
0.06% 163
2022
Q2
$356 Hold
3,740
0.07% 171
2022
Q1
$440 Hold
3,740
0.07% 171
2021
Q4
$485 Hold
3,740
0.08% 162
2021
Q3
$423K Sell
3,740
-200
-5% -$22.8K 0.07% 171
2021
Q2
$408K Sell
3,940
-100
-2% -$9.43K 0.07% 179
2021
Q1
$338K Hold
4,040
0.06% 195
2020
Q4
$369K Hold
4,040
0.07% 167
2020
Q3
$322K Buy
+4,040
New +$315K 0.08% 158

Other funds holding EW

Baldwin Investment Management's EW Position: Q1 2026 in Review

Baldwin Investment Management reduced its Edwards Lifesciences (EW) stake by 5.1% in Q1 2026, selling an estimated $63.9K and leaving 14,320 shares worth $1.15M. The position accounts for 0.13% of the portfolio, ranked #90.

Baldwin Investment Management first reported a position in EW in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.29M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Baldwin Investment Management held 14,320 shares of Edwards Lifesciences worth $1.15M as of Q1 2026.
  • Baldwin Investment Management sold 775 Edwards Lifesciences shares in Q1 2026, an estimated $63.9K.
  • Edwards Lifesciences made up 0.13% of Baldwin Investment Management's portfolio in Q1 2026, its #90 holding.
  • Baldwin Investment Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 20 quarters since.
  • Baldwin Investment Management's Edwards Lifesciences position peaked at $1.29M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.